Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 12
Submit an article Journal homepage
6,630
Views
103
CrossRef citations to date
0
Altmetric
Review

Trial watch: Peptide-based vaccines in anticancer therapy

Lucillia BezuFaculty of Medicine, University of Paris Sud/Paris XI, Le Kremlin-Bicêtre, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers,Paris, France;U1138, INSERM, Paris, France;Université Paris Descartes/Paris V, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, FranceORCID Iconhttp://orcid.org/0000-0002-3569-6066
ORCID Icon,
Oliver KeppMetabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers,Paris, France;U1138, INSERM, Paris, France;Université Paris Descartes/Paris V, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, FranceORCID Iconhttp://orcid.org/0000-0002-6081-9558
ORCID Icon,
Giulia CerratoMetabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers,Paris, France;U1138, INSERM, Paris, France;Université Paris Descartes/Paris V, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France
,
Jonathan PolMetabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers,Paris, France;U1138, INSERM, Paris, France;Université Paris Descartes/Paris V, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France
,
Jitka FucikovaSotio, Prague, Czech Republic;Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic
,
Radek SpisekSotio, Prague, Czech Republic;Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic
,
Laurence ZitvogelFaculty of Medicine, University of Paris Sud/Paris XI, Le Kremlin-Bicêtre, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;INSERM, U1015, Gustave Roussy Cancer Campus, Villejuif, France
,
Guido KroemerMetabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France;Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers,Paris, France;U1138, INSERM, Paris, France;Université Paris Descartes/Paris V, Paris, France;Université Pierre et Marie Curie/Paris VI, Paris, France;Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, SwedenORCID Iconhttp://orcid.org/0000-0002-9334-4405
ORCID Icon &
Lorenzo GalluzziUniversité Paris Descartes/Paris V, Paris, France;Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;Sandra and Edward Meyer Cancer Center, New York, NY, USACorrespondence[email protected]
 show all
Article: e1511506 | Received 10 Aug 2018, Published online: 06 Sep 2018

Citations (103)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Amit Lath, Anita Rani Santal, Nameet Kaur, Poonam Kumari & Nater Pal Singh. (2023) Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnology and Genetic Engineering Reviews 39:1, pages 45-84.
Read now
Mi Tang, Jiang-Hui Cai, Hao-Yang Diao, Wen-Mei Guo, Xiao Yang & ShaSha Xing. (2022) The progress of peptide vaccine clinical trials in gynecologic oncology. Human Vaccines & Immunotherapeutics 18:5.
Read now
Sana Batool, Duaa Bin-T-Abid, Hina Batool, Saher Shahid, Mahjabeen Saleem, Azmat Ullah Khan, Arslan Hamid, Malik Siddique Mahmood & Naeem Mahmood Ashraf. (2021) Development of multi-epitope vaccine constructs for non-small cell lung cancer (NSCLC) against USA human leukocyte antigen background: an immunoinformatic approach toward future vaccine designing. Expert Opinion on Biological Therapy 21:11, pages 1525-1533.
Read now
Yina Cun, Chuanyin Li, Lei Shi, Ming Sun, Shuying Dai, Le Sun, Li Shi & Yufeng Yao. (2021) COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations. Human Vaccines & Immunotherapeutics 17:4, pages 1097-1108.
Read now
Abdelrahman H. Abdelmoneim, Mujahed I. Mustafa, Miyssa I. Abdelmageed, Naseem S. Murshed, Enas dk. Dawoud, Enas M. Ahmed, Rahma M. Kamal Eldein, Nafisa M. Elfadol, Anfal Osama M. Sati & Abdelrafie M. Makhawi. (2021) Immunoinformatics design of multiepitopes peptide-based universal cancer vaccine using matrix metalloproteinase-9 protein as a target. Immunological Medicine 44:1, pages 35-52.
Read now
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer & Jonathan G. Pol. (2021) Trial watch: intratumoral immunotherapy. OncoImmunology 10:1.
Read now
Ying Peng, Xiang-Xiang Zhan, Yi Cao, Han-Wen Zhang, Wei-Han Cao, Yan-Jun Su, Chang Diao, Qiang-Ming Sun & Ruo-Chuan Cheng. (2020) The Potential Action of Thomsen–Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer. OncoTargets and Therapy 13, pages 8677-8689.
Read now
Hiroaki Mashima, Rong Zhang, Tsuyoshi Kobayashi, Yuichiro Hagiya, Hirotake Tsukamoto, Tianyi Liu, Tatsuaki Iwama, Masateru Yamamoto, Chiahsuan Lin, Ryusuke Nakatsuka, Yuta Mishima, Noriko Watanabe, Takashi Yamada, Satoru Senju, Shin Kaneko, Alimjan Idiris, Tetsuya Nakatsura, Hideki Ohdan & Yasushi Uemura. (2020) Generation of GM-CSF-producing antigen-presenting cells that induce a cytotoxic T cell-mediated antitumor response. OncoImmunology 9:1.
Read now
Giorgio Frega, Qi Wu, Julie Le Naour, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer & Oliver Kepp. (2020) Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. OncoImmunology 9:1.
Read now
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer & Erika Vacchelli. (2020) Trial watch: TLR3 agonists in cancer therapy. OncoImmunology 9:1.
Read now
Yoshiro Nakahara, Taku Kouro, Yuka Igarashi, Mamoru Kawahara & Tetsuro Sasada. (2019) Prospects for a personalized peptide vaccine against lung cancer. Expert Review of Vaccines 18:7, pages 703-709.
Read now

Articles from other publishers (92)

Fatemeh Zahedipour, Khadijeh Jamialahmadi, Parvin Zamani & Mahmoud Reza Jaafari. (2023) Improving the efficacy of peptide vaccines in cancer immunotherapy. International Immunopharmacology 123, pages 110721.
Crossref
Thao N. Nguyen, Hamid Teimouri & Anatoly B. Kolomeisky. (2023) Increasing Heterogeneity in Antimicrobial Peptide Combinations Enhances Their Synergistic Activities. The Journal of Physical Chemistry Letters, pages 8405-8411.
Crossref
Hong Zhou, Yipeng Ma, Fenglan Liu, Bin Li, Dongjuan Qiao, Peigen Ren & Mingjun Wang. (2023) Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment. Frontiers in Immunology 14.
Crossref
Douglas G. Millar, S. Y. Cindy Yang, Azin Sayad, Qingchuan Zhao, Linh T. Nguyen, Kathrin Warner, Ami G. Sangster, Munehide Nakatsugawa, Kenji Murata, Ben X. Wang, Patricia Shaw, Blaise Clarke, Marcus Q. Bernardini, Trevor Pugh, Pierre Thibault, Naoto Hirano, Claude Perreault & Pamela S. Ohashi. (2023) Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire. Cancer Immunology, Immunotherapy 72:7, pages 2375-2392.
Crossref
Hamid Aria & Marzieh Rezaei. (2023) Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives. Biomedicine & Pharmacotherapy 161, pages 114503.
Crossref
Ranran Shi, Xiuman Zhou, Liwei Pang, Mingshuang Wang, Yubing Li, Chunxia Chen, Haoming Ning, Lihan Zhang, Guangxing Yue, Lu Qiu, Wenshan Zhao, Yuanming Qi, Yahong Wu & Yanfeng Gao. (2022) Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer. Cancer Immunology, Immunotherapy 72:4, pages 985-1001.
Crossref
Melek P. Khalily & Medine Soydan. (2022) Peptide‐based diagnostic and therapeutic agents: Where we are and where we are heading?. Chemical Biology & Drug Design 101:3, pages 772-793.
Crossref
Doriana Iancu, Ana Fulga, Doina Vesa, Constantin Stan, Andrei Zenovia, Florin Bujoreanu, Alin Piraianu, Mihaela Sarbu & Alin Tatu. (2023) Insight on common forms of cutaneous head and neck carcinoma (Review). Molecular and Clinical Oncology 18:4.
Crossref
Kazuhiro Mochizuki. (2023) Harnessing allogeneic CD4<sup>+</sup> T cells to reinvigorate host endogenous antitumor immunity. FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 69:3, pages 157-165.
Crossref
Md Mijanur Rahman, Md Habib Ullah Masum, Asma Talukder & Rekha Akter. (2023) An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers. Informatics in Medicine Unlocked 37, pages 101169.
Crossref
Qilong Zhou, Wei Wu, Kaimin Jia, Guangyan Qi, Xiuzhi Susan Sun & Ping Li. (2022) Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1. European Journal of Medicinal Chemistry 244, pages 114830.
Crossref
Karima El Hauadi, Leonor Resina, David Zanuy, Teresa Esteves, Frederico Castelo Ferreira, Maria M. Pérez-Madrigal & Carlos Alemán. (2022) Dendritic Self-assembled Structures from Therapeutic Charged Pentapeptides. Langmuir 38:42, pages 12905-12914.
Crossref
Thao N. Nguyen, Hamid Teimouri, Angela Medvedeva & Anatoly B. Kolomeisky. (2022) Cooperativity in Bacterial Membrane Association Controls the Synergistic Activities of Antimicrobial Peptides. The Journal of Physical Chemistry B 126:38, pages 7365-7372.
Crossref
Unnati Patel, Kavini Rathnayake, Emily C. Hunt & Nirupama Singh. (2022) Role of Nanomaterials in COVID-19 Prevention, Diagnostics, Therapeutics, and Vaccine Development. Journal of Nanotheranostics 3:4, pages 151-176.
Crossref
Saloni Ramani, Sayalee Samant & Sonal M Manohar. (2022) The story of EGFR: from signaling pathways to a potent anticancer target. Future Medicinal Chemistry 14:17, pages 1267-1288.
Crossref
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Tejeda-Benítez, Lucellys Sierra-Márquez, María Cabarcas-Montalvo, María García-Espiñeira, Wilfrido Coronell-Rodríguez & Bárbara Arroyo-Salgado. (2022) Vaccines platforms and COVID-19: what you need to know. Tropical Diseases, Travel Medicine and Vaccines 8:1.
Crossref
Debopriya Bose, Laboni Roy & Subhrangsu Chatterjee. (2022) Peptide therapeutics in the management of metastatic cancers. RSC Advances 12:33, pages 21353-21373.
Crossref
Madhura Modak, Ann-Kathrin Mattes, Daniela Reiss, Wioletta Skronska-Wasek, Rebecca Langlois, Nicolas Sabarth, Renate Konopitzky, Fidel Ramirez, Katharina Lehr, Tobias Mayr, David Kind, Coralie Viollet, Lee Kim Swee, Jutta Petschenka, Karim C. El Kasmi, Elfriede Noessner, Kerstin Kitt & Stefan Pflanz. (2022) CD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity. JCI Insight 7:11.
Crossref
Jiao Wei & Ai-Min Hui. (2022) The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines. Cancer Treatment Reviews 107, pages 102405.
Crossref
Shigetaka Suekane, Shigeru Yutani, Uhi Toh, Koichi Yoshiyama & Kyogo Itoh. (2022) Immune responses of patients without cancer recurrence after a cancer vaccine over a long term. Molecular and Clinical Oncology 16:6.
Crossref
Rodrigo Ochoa, Victoria Alves Santos Lunardelli, Daniela Santoro Rosa, Alessandro Laio & Pilar Cossio. (2022) Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol. Frontiers in Immunology 13.
Crossref
Timothy Samec, Jessica Boulos, Serena Gilmore, Anthony Hazelton & Angela Alexander-Bryant. (2022) Peptide-based delivery of therapeutics in cancer treatment. Materials Today Bio 14, pages 100248.
Crossref
Han Lin, Kun Wang, Yuxin Xiong, Liting Zhou, Yong Yang, Shanwei Chen, Peihong Xu, Yujun Zhou, Rui Mao, Guangzhao Lv, Peng Wang & Dong Zhou. (2022) Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. Frontiers in Immunology 13.
Crossref
Takushi Yasuda, Kohei Nishiki, Yoko Hiraki, Hiroaki Kato, Mitsuru Iwama, Osamu Shiraishi, Atsushi Yasuda, Masayuki Shinkai, Yutaka Kimura, Yasushi Sukegawa, Yasutaka Chiba, Motohiro Imano, Kazuyoshi Takeda, Takao Satou, Hitoshi Shiozaki & Yusuke Nakamura. (2022) Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects. Annals of Surgery 275:1, pages e155-e162.
Crossref
Kundan K. Rajak. 2022. Understanding Cancer. Understanding Cancer 269 286 .
Meghna Amrita Singh, Tarani Prakash Shrivastava, Ajay Sharma & Madhu Gupta. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges 295 311 .
Zhe Sun, Xiaodong Sun, Zhanwei Chen, Juan Du & Yihua Wu. (2021) Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines. International Journal of Peptide Research and Therapeutics 28:1.
Crossref
Shubham Mule, Mayank Handa & Rahul Shukla. 2022. Hormone Related Cancer Mechanistic and Nanomedicines. Hormone Related Cancer Mechanistic and Nanomedicines 325 347 .
Alexander S. Roesler & Karen S. Anderson. 2022. Vaccine Design. Vaccine Design 649 670 .
Takayuki Nakagawa, Tetsuya Tanino, Motoyasu Onishi, Soichi Tofukuji, Takayuki Kanazawa, Yukichi Ishioka, Takeshi Itoh, Akira Kugimiya, Kazufumi Katayama, Takuya Yamamoto, Morio Nagira & Ken J. Ishii. (2021) S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes. Frontiers in Immunology 12.
Crossref
Pengxiang Yang, Yong Peng, Yuan Feng, Zhuoying Xu, Panfeng Feng, Jie Cao, Ying Chen, Xiang Chen, Xingjian Cao, Yumin Yang & Jing Jie. (2021) Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Kazuhiro Mochizuki, Shogo Kobayashi, Nobuhisa Takahashi, Kotaro Sugimoto, Hideki Sano, Yoshihiro Ohara, Shin Mineishi, Yi Zhang & Atsushi Kikuta. (2021) Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Muhammad Luqman Nordin, Abdin Shakirin Mohamad Norpi, Pei Yuen Ng, Khatijah Yusoff, Nadiah Abu, Kue Peng Lim & Fazren Azmi. (2021) HER2/neu-Based Peptide Vaccination-Pulsed with B-Cell Epitope Induced Efficient Prophylactic and Therapeutic Antitumor Activities in TUBO Breast Cancer Mice Model. Cancers 13:19, pages 4958.
Crossref
Xiaoyue Yang, Jiansheng Fan, Yue Wu, Zhiming Ma, Jin Huang, Ying Zhang, Zhan Zhou, Fan Mo, Xuerong Liu, Hong Yuan, Yingchun Xu, Liqiang Pan & Shuqing Chen. (2021) Synthetic multiepitope neoantigen DNA vaccine for personalized cancer immunotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 37, pages 102443.
Crossref
Laurence Zitvogel, Claude Perreault, Olivera J. Finn & Guido Kroemer. (2021) Beneficial autoimmunity improves cancer prognosis. Nature Reviews Clinical Oncology 18:9, pages 591-602.
Crossref
Milda Naciute, Tamara Kiwitt, Roslyn A. Kemp & Sarah Hook. (2021) Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration. Vaccine 39:39, pages 5589-5599.
Crossref
Heidi Jones, Victoria Green, James England & John Greenman. (2021) Current understanding of nonsurgical interventions for refractory differentiated thyroid cancer: a systematic review. Future Science OA 7:7.
Crossref
David J. Peeler, Albert Yen, Nicholas Luera, Patrick S. Stayton & Suzie H. Pun. (2021) Lytic Polyplex Vaccines Enhance Antigen‐Specific Cytotoxic T Cell Response through Induction of Local Cell Death. Advanced Therapeutics 4:8.
Crossref
Chang-Gon Kim, Yun-Beom Sang, Ji-Hyun Lee & Hong-Jae Chon. (2021) Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach. International Journal of Molecular Sciences 22:15, pages 8035.
Crossref
Eric de Sousa, Joana R. Lérias, Antonio Beltran, Georgia Paraschoudi, Carolina Condeço, Jéssica Kamiki, Patrícia Alexandra António, Nuno Figueiredo, Carlos Carvalho, Mireia Castillo-Martin, Zhe Wang, Dário Ligeiro, Martin Rao & Markus Maeurer. (2021) Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery. Frontiers in Immunology 12.
Crossref
DaeYong Lee, Kristin Huntoon, Yifan Wang, Wen Jiang & Betty Y. S. Kim. (2021) Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy. Advanced Materials 33:27.
Crossref
Alexander J. Stephens, Nicola A. Burgess-Brown & Shisong Jiang. (2021) Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines. Frontiers in Immunology 12.
Crossref
Kai-Yao Huang, Yi-Jhan Tseng, Hui-Ju Kao, Chia-Hung Chen, Hsiao-Hsiang Yang & Shun-Long Weng. (2021) Identification of subtypes of anticancer peptides based on sequential features and physicochemical properties. Scientific Reports 11:1.
Crossref
Apratim Jash, Ali Ubeyitogullari & Syed S. H. Rizvi. (2021) Liposomes for oral delivery of protein and peptide-based therapeutics: challenges, formulation strategies, and advances. Journal of Materials Chemistry B 9:24, pages 4773-4792.
Crossref
Howard Donninger, Chi Li, John W. Eaton & Kavitha Yaddanapudi. (2021) Cancer Vaccines: Promising Therapeutics or an Unattainable Dream. Vaccines 9:6, pages 668.
Crossref
Weiteng An, Sira Defaus, David Andreu & Pilar Rivera-Gil. (2021) In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers. Frontiers in Immunology 12.
Crossref
Zhengguo Wu, Shang Li & Xiao Zhu. (2021) The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity. Frontiers in Immunology 12.
Crossref
Jitian Li, Bo Qin, Manyu Huang, Yan Ma, Dongsheng Li, Wuyin Li & Zhiping Guo. (2021) Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma. Frontiers in Immunology 12.
Crossref
Malak Abedalthagafi, Nahla Mobark, May Al-Rashed & Musa AlHarbi. (2021) Epigenomics and immunotherapeutic advances in pediatric brain tumors. npj Precision Oncology 5:1.
Crossref
Kui Chen, Yujiao Wang, Haojun Liang, Huan Huang, Yuelan Liang, Jiaxin Zhang, Ya-nan Chang, Juan Li, Min Fang & Gengmei Xing. (2021) Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure. Nano Today 37, pages 101070.
Crossref
Xuedan He, Shiqi Zhou, Wei-Chiao Huang, Amal Seffouh, Moustafa T. Mabrouk, M. Thomas Morgan, Joaquin Ortega, Scott I. Abrams & Jonathan F. Lovell. (2021) A Potent Cancer Vaccine Adjuvant System for Particleization of Short, Synthetic CD8 + T Cell Epitopes . ACS Nano 15:3, pages 4357-4371.
Crossref
Kavya Rakhra, Wuhbet AbrahamChensu Wang, Kelly D. Moynihan, Na LiNathan DonahueAlexis D. BaldeonDarrell J. Irvine. (2021) Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells. Science Immunology 6:57.
Crossref
Priyanka Dash, Subhashree Mohapatra, Sayantan Ghosh & Bismita Nayak. (2021) A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review. Frontiers in Pharmacology 11.
Crossref
Bassel Akache, Gerard Agbayani, Felicity C. Stark, Yimei Jia, Renu Dudani, Blair A. Harrison, Lise Deschatelets, Vandana Chandan, Edmond Lam, Usha D. Hemraz, Sophie Régnier, Lakshmi Krishnan & Michael J. McCluskie. (2021) Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model. Pharmaceutics 13:2, pages 257.
Crossref
Hannah E Olsen, Geoffrey M Lynn, Pablo A Valdes, Christian D Cerecedo Lopez, Andrew S Ishizuka, Omar Arnaout, W Linda Bi, Pier Paolo Peruzzi, E Antonio Chiocca, Gregory K Friedman & Joshua D Bernstock. (2021) Therapeutic cancer vaccines for pediatric malignancies: advances, challenges, and emerging technologies. Neuro-Oncology Advances 3:1.
Crossref
Jitka Fucikova, Radek Spisek, Guido Kroemer & Lorenzo Galluzzi. (2020) Calreticulin and cancer. Cell Research 31:1, pages 5-16.
Crossref
Anna Reustle, Moreno Di Marco, Carolin Meyerhoff, Annika Nelde, Juliane S. Walz, Stefan Winter, Siahei Kandabarau, Florian Büttner, Mathias Haag, Linus Backert, Daniel J. Kowalewski, Steffen Rausch, Jörg Hennenlotter, Viktoria Stühler, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Hans-Georg Rammensee, Jens Bedke, Stefan Stevanović, Matthias Schwab & Elke Schaeffeler. (2020) Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. Genome Medicine 12:1.
Crossref
Seren Hamsici, Gokhan Gunay, Hande Kirit, Advika Kamatar, Kendrick Loving & Handan Acar. 2020. Peptide-based Biomaterials. Peptide-based Biomaterials 291 334 .
Sujit S. Nair, Rachel Weil, Zachary Dovey, Avery Davis & Ashutosh K. Tewari. (2020) The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer. Urologic Clinics of North America 47:4, pages e17-e54.
Crossref
A-Ri Shin, Sang-Eun Lee, Haeyoun Choi, Hyun-Jung Sohn, Hyun-Il Cho & Tai-Gyu Kim. (2020) An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia. British Journal of Cancer 123:6, pages 919-931.
Crossref
Anca Apavaloaei, Marie-Pierre Hardy, Pierre Thibault & Claude Perreault. (2020) The Origin and Immune Recognition of Tumor-Specific Antigens. Cancers 12:9, pages 2607.
Crossref
Eric P Grewal, Courtney L Erskine, Wendy K Nevala, Jacob B Allred, Carrie A Strand, Lisa A Kottschade, Robert R McWilliams, Roxana S Dronca, Adam J Yakovich, Svetomir N Markovic & Matthew S Block. (2020) Peptide vaccine with glucopyranosyl lipid A–stable oil-in-water emulsion for patients with resected melanoma. Immunotherapy 12:13, pages 983-995.
Crossref
Uhi Toh, Sayaka Sakurai, Shuko Saku, Yuko Takao, Mina Okabe, Nobutaka Iwakuma, Shigeki Shichijo, Akira Yamada, Kyogo Itoh & Yoshito Akagi. (2020) Early phase II study of mixed 19‐peptide vaccine monotherapy for refractory triple‐negative breast cancer. Cancer Science 111:8, pages 2760-2769.
Crossref
Matthew D. Shin, Sourabh Shukla, Young Hun Chung, Veronique Beiss, Soo Khim Chan, Oscar A. Ortega-Rivera, David M. Wirth, Angela Chen, Markus Sack, Jonathan K. Pokorski & Nicole F. Steinmetz. (2020) COVID-19 vaccine development and a potential nanomaterial path forward. Nature Nanotechnology 15:8, pages 646-655.
Crossref
Masao Nakajima, Shoichi Hazama, Koji Tamada, Keiko Udaka, Yasunobu Kouki, Toshinari Uematsu, Hideki Arima, Akira Saito, Shun Doi, Hiroto Matsui, Yoshitaro Shindo, Satoshi Matsukuma, Shinsuke Kanekiyo, Yukio Tokumitsu, Shinobu Tomochika, Michihisa Iida, Shin Yoshida, Yuki Nakagami, Nobuaki Suzuki, Shigeru Takeda, Shigeru Yamamoto, Shigefumi Yoshino, Tomio Ueno & Hiroaki Nagano. (2020) A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trial. Cancer Immunology, Immunotherapy 69:8, pages 1651-1662.
Crossref
Marthe C. J. RoexLois HagemanSabrina A. J. VeldEsther van EgmondConny HoogstratenChristian Stemberger, Lothar Germeroth, Hermann Einsele, J. H. Frederik FalkenburgInge Jedema. (2020) A minority of T cells recognizing tumor-associated antigens presented in self-HLA can provoke antitumor reactivity. Blood 136:4, pages 455-467.
Crossref
Diana Campillo-Davo, Donovan Flumens & Eva Lion. (2020) The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses. Cells 9:7, pages 1720.
Crossref
Milda Naciute, Virginia Niemi, Roslyn A. Kemp & Sarah Hook. (2020) Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer. European Journal of Pharmaceutics and Biopharmaceutics 152, pages 183-192.
Crossref
Masahiro Okada, Kanako Shimizu, Tomonori Iyoda, Shogo Ueda, Jun Shinga, Yoshiki Mochizuki, Takashi Watanabe, Osamu Ohara & Shin-ichiro Fujii. (2020) PD-L1 Expression Affects Neoantigen Presentation. iScience 23:6, pages 101238.
Crossref
Sepideh Parvizpour, Mohammad M. Pourseif, Jafar Razmara, Mohammad A. Rafi & Yadollah Omidi. (2020) Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches. Drug Discovery Today 25:6, pages 1034-1042.
Crossref
Masanori Noguchi, Gaku Arai, Shin Egawa, Chikara Ohyama, Seiji Naito, Kazumasa Matsumoto, Hirotsugu Uemura, Masayuki Nakagawa, Yasutomo Nasu, Masatoshi Eto, Shigetaka Suekane, Tetsuro Sasada, Shigeki Shichijo, Akira Yamada, Tatsuyuki Kakuma & Kyogo Itoh. (2020) Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial. Cancer Immunology, Immunotherapy 69:5, pages 847-857.
Crossref
Rachid Bouzid, Maikel Peppelenbosch & Sonja I. Buschow. (2020) Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review. Cancers 12:5, pages 1121.
Crossref
Anne S. De Groot, Leonard Moise, Frances Terry, Andres H. Gutierrez, Pooja Hindocha, Guilhem Richard, Daniel Fredric Hoft, Ted M. Ross, Amy R. Noe, Yoshimasa Takahashi, Vinayaka Kotraiah, Sarah E. Silk, Carolyn M. Nielsen, Angela M. Minassian, Rebecca Ashfield, Matt Ardito, Simon J. Draper & William D. Martin. (2020) Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools. Frontiers in Immunology 11.
Crossref
Brian W. Simons, Fabiana Cannella, Dayana T. Rowley & Raphael P. Viscidi. (2020) Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model. Cancer Immunology, Immunotherapy 69:4, pages 641-651.
Crossref
Sandra Santos-Sierra. (2020) Developments in anticancer vaccination: budding new adjuvants. Biological Chemistry 401:4, pages 435-446.
Crossref
Shigetaka Suekane, Shigeru Yutani, Akira Yamada, Tetsuro Sasada, Satoko Matsueda, Shinzo Takamori, Uhi Toh, Kouichiro Kawano, Koichi Yoshiyama, Shinjiro Sakamoto, Shunichi Sugawara, Nobukazu Komatsu, Teppei Yamada, Masayasu Naito, Mizuhiko Terasaki, Takashi Mine, Kyogo Itoh, Shigeki Shichijo & Masanori Noguchi. (2020) Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients. International Journal of Oncology.
Crossref
Hoang-Thanh Le, Nya L. Fraleigh, Jordan D. Lewicky, Justin Boudreau, Paul Dolinar, Nitin Bhardwaj, Francisco Diaz-Mitoma, Sabine Montaut, Sarah Fallahi & Alexandrine L. Martel. (2020) Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small “Non-Natural” Peptides. Molecules 25:6, pages 1290.
Crossref
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch, Dobrin Draganov, Richard L Edelson, Silvia C Formenti, Jitka Fucikova, Lucia Gabriele, Udo S Gaipl, Sofia R Gameiro, Abhishek D Garg, Encouse Golden, Jian Han, Kevin J Harrington, Akseli Hemminki, James W Hodge, Dewan Md Sakib Hossain, Tim Illidge, Michael Karin, Howard L Kaufman, Oliver Kepp, Guido Kroemer, Juan Jose Lasarte, Sherene Loi, Michael T Lotze, Gwenola Manic, Taha Merghoub, Alan A Melcher, Karen L Mossman, Felipe Prosper, Øystein Rekdal, Maria Rescigno, Chiara Riganti, Antonella Sistigu, Mark J Smyth, Radek Spisek, John Stagg, Bryan E Strauss, Daolin Tang, Kazuki Tatsuno, Stefaan W van Gool, Peter Vandenabeele, Takahiro Yamazaki, Dmitriy Zamarin, Laurence Zitvogel, Alessandra Cesano & Francesco M Marincola. (2020) Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal for ImmunoTherapy of Cancer 8:1, pages e000337.
Crossref
Ying Cai, Wei Ran, Yihui Zhai, Junyang Wang, Chao Zheng, Yaping Li & Pengcheng Zhang. (2020) Recent progress in supramolecular peptide assemblies as virus mimics for cancer immunotherapy. Biomaterials Science 8:4, pages 1045-1057.
Crossref
Stephanie J. Crowley, Patrick T. Bruck, Md Aladdin Bhuiyan, Amelia Mitchell-Gears, Michael J. Walsh, Kevin Zhangxu, Lestat R. Ali, Hee-Jin Jeong, Jessica R. Ingram, David M. Knipe, Hidde L. Ploegh, Michael Dougan & Stephanie K. Dougan. (2020) Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH. Open Biology 10:2.
Crossref
Stéphanie Corgnac, Natalia K. Botelho, Alena Donda & Pedro Romero. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part B. Tumor Immunology and Immunotherapy – Cellular Methods Part B 521 543 .
Yoshie Kametani, Yusuke Ohno, Shino Ohshima, Banri Tsuda, Atsushi Yasuda, Toshiro Seki, Ryoji Ito & Yutaka Tokuda. (2019) Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 20:24, pages 6337.
Crossref
Bérangère Avalle, Séverine Padiolleau-Lefevre & Alain Friboulet. (2019) Structural and Functional Mise en Abyme. Frontiers in Molecular Biosciences 6.
Crossref
Carmen Murias Henriquez, Hendrik-Tobias Arkenau, Valérie Dutoit & Anna Patrikidou. 2019. Cancer Immunotherapy and Biological Cancer Treatments. Cancer Immunotherapy and Biological Cancer Treatments.
Anastasios I. Birmpilis, Chrysoula-Evangelia Karachaliou, Pinelopi Samara, Kyriaki Ioannou, Platon Selemenakis, Ioannis V. Kostopoulos, Nadia Kavrochorianou, Hubert Kalbacher, Evangelia Livaniou, Sylva Haralambous, Athanasios Kotsinas, Farzin Farzaneh, Ioannis P. Trougakos, Wolfgang Voelter, Meletios-Athanasios Dimopoulos, Aristotelis Bamias & Ourania Tsitsilonis. (2019) Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide. Cancers 11:11, pages 1764.
Crossref
Hiroki Tsukamoto, Kanae Kubota, Ayumi Shichiku, Masamitsu Maekawa, Nariyasu Mano, Hideo Yagita, Shoichiro Ohta & Yoshihisa Tomioka. (2019) An agonistic anti‐Toll‐like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy. Immunology 158:2, pages 136-149.
Crossref
Michal A. Rahat. (2019) Targeting Angiogenesis With Peptide Vaccines. Frontiers in Immunology 10.
Crossref
Marta Calvo Tardón, Mathilde Allard, Valérie Dutoit, Pierre-Yves Dietrich & Paul R Walker. (2019) Peptides as cancer vaccines. Current Opinion in Pharmacology 47, pages 20-26.
Crossref
Xiaoming Ouyang, Melinda L. Telli & Joseph C. Wu. (2019) Induced Pluripotent Stem Cell-Based Cancer Vaccines. Frontiers in Immunology 10.
Crossref
Chunye Zhang, Ming Yang & Aaron C. Ericsson. (2019) Antimicrobial Peptides: Potential Application in Liver Cancer. Frontiers in Microbiology 10.
Crossref
Susumu Iiizumi, Junya Ohtake, Naoko Murakami, Taku Kouro, Mamoru Kawahara, Fumiko Isoda, Hiroshi Hamana, Hiroyuki Kishi, Norihiro Nakamura & Tetsuro Sasada. (2019) Identification of Novel HLA Class II-Restricted Neoantigens Derived from Driver Mutations. Cancers 11:2, pages 266.
Crossref
Mouldy Sioud. (2019) Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy. Cancers 11:2, pages 176.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.